Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Effect of Liraglutide or Glimepiride Added to Metformin on Glycaemic Control in Subjects With Type 2 Diabetes
Brief Summary: This trial is conducted in Asia. The trial is designed to compare the effect on glycaemic control of liraglutide or glimepiride added to metformin in subjects with type 2 diabetes


Options:
A: Arm Label: BI 1356 (5 mg); Type: EXPERIMENTAL; Interventions: Drug: Linagliptin + pioglitazone (30 mg) | Arm Label: Placebo matching BI 1356 5 mg; Type: PLACEBO_COMPARATOR; Interventions: Drug: placebo + pioglitazone (30 mg) | Intervention Type: DRUG; Name: placebo + pioglitazone (30 mg); Assigned to Arm(s): Placebo matching BI 1356 5 mg | Intervention Type: DRUG; Name: Linagliptin + pioglitazone (30 mg); Assigned to Arm(s): BI 1356 (5 mg)
B: Arm Label: metformin + glimepiride + pioglitazone + albiglutide placebo; Type: ACTIVE_COMPARATOR; Interventions: Drug: placebo to match albiglutide, Drug: metformin, Drug: glimepiride, Drug: pioglitazone | Arm Label: metformin + glimepiride + pioglitazone placebo + albiglutide; Type: EXPERIMENTAL; Interventions: Biological: albiglutide, Drug: metformin, Drug: glimepiride, Drug: placebo to match pioglitazone | Arm Label: met + glimepiride + pioglitazone placebo + albiglutide placebo; Type: ACTIVE_COMPARATOR; Interventions: Drug: placebo to match albiglutide, Drug: metformin, Drug: glimepiride, Drug: placebo to match pioglitazone | Intervention Type: DRUG; Name: placebo to match albiglutide; Assigned to Arm(s): met + glimepiride + pioglitazone placebo + albiglutide placebo, metformin + glimepiride + pioglitazone + albiglutide placebo | Intervention Type: BIOLOGICAL; Name: albiglutide; Assigned to Arm(s): metformin + glimepiride + pioglitazone placebo + albiglutide | Intervention Type: DRUG; Name: metformin; Assigned to Arm(s): met + glimepiride + pioglitazone placebo + albiglutide placebo, metformin + glimepiride + pioglitazone + albiglutide placebo, metformin + glimepiride + pioglitazone placebo + albiglutide | Intervention Type: DRUG; Name: glimepiride; Assigned to Arm(s): met + glimepiride + pioglitazone placebo + albiglutide placebo, metformin + glimepiride + pioglitazone + albiglutide placebo, metformin + glimepiride + pioglitazone placebo + albiglutide | Intervention Type: DRUG; Name: pioglitazone; Assigned to Arm(s): metformin + glimepiride + pioglitazone + albiglutide placebo | Intervention Type: DRUG; Name: placebo to match pioglitazone; Assigned to Arm(s): met + glimepiride + pioglitazone placebo + albiglutide placebo, metformin + glimepiride + pioglitazone placebo + albiglutide
C: Arm Label: Lira 0.6 + Met; Type: EXPERIMENTAL; Interventions: Drug: liraglutide, Drug: placebo, Drug: metformin | Arm Label: Lira 1.2 + Met; Type: EXPERIMENTAL; Interventions: Drug: placebo, Drug: liraglutide, Drug: metformin | Arm Label: Lira 1.8 + Met; Type: EXPERIMENTAL; Interventions: Drug: placebo, Drug: liraglutide, Drug: metformin | Arm Label: Glim + Met; Type: EXPERIMENTAL; Interventions: Drug: glimepiride, Drug: metformin, Drug: placebo | Intervention Type: DRUG; Name: liraglutide; Assigned to Arm(s): Lira 0.6 + Met | Intervention Type: DRUG; Name: placebo; Assigned to Arm(s): Lira 0.6 + Met, Lira 1.2 + Met, Lira 1.8 + Met | Intervention Type: DRUG; Name: liraglutide; Assigned to Arm(s): Lira 1.2 + Met | Intervention Type: DRUG; Name: liraglutide; Assigned to Arm(s): Lira 1.8 + Met | Intervention Type: DRUG; Name: glimepiride; Assigned to Arm(s): Glim + Met | Intervention Type: DRUG; Name: metformin; Assigned to Arm(s): Glim + Met, Lira 0.6 + Met, Lira 1.2 + Met, Lira 1.8 + Met | Intervention Type: DRUG; Name: placebo; Assigned to Arm(s): Glim + Met
D: Arm Label: rosiglitazone in addition to background metformin; Type: EXPERIMENTAL; Interventions: Drug: Rosiglitazone, Drug: Metformin | Arm Label: rosiglitazone in addition to background sulfonylurea; Type: EXPERIMENTAL; Interventions: Drug: Rosiglitazone, Drug: Sulfonylurea | Arm Label: Sulfonylurea in addition to background metformin; Type: ACTIVE_COMPARATOR; Interventions: Drug: Sulfonylurea, Drug: Metformin | Arm Label: Metformin in addition to background sulfonylurea; Type: ACTIVE_COMPARATOR; Interventions: Drug: Sulfonylurea, Drug: Metformin | Intervention Type: DRUG; Name: Rosiglitazone; Assigned to Arm(s): rosiglitazone in addition to background metformin, rosiglitazone in addition to background sulfonylurea | Intervention Type: DRUG; Name: Sulfonylurea; Assigned to Arm(s): Metformin in addition to background sulfonylurea, Sulfonylurea in addition to background metformin, rosiglitazone in addition to background sulfonylurea | Intervention Type: DRUG; Name: Metformin; Assigned to Arm(s): Metformin in addition to background sulfonylurea, Sulfonylurea in addition to background metformin, rosiglitazone in addition to background metformin

Answer: C